Filing Details
- Accession Number:
- 0001238403-24-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-04 17:57:26
- Reporting Period:
- 2024-06-03
- Accepted Time:
- 2024-06-04 17:57:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238403 | K Daniel Spiegelman | 322 North 2200 West Salt Lake City UT 84116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-03 | 3,788 | $22.04 | 36,705 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-04 | 3,788 | $22.05 | 32,917 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.